Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

R Nasreddine, E Florence, B Vandercam, M Moutschen… - AIDS, 2020 - journals.lww.com
Objective: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in a
'real-world setting'in Belgium. Design: Retrospective, observational, multicenter cohort …

[PDF][PDF] Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

R Nasreddine, E Florence, B Vandercam, M Moutschen… - AIDS, 2020 - dial.uclouvain.be
Objective: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in a
'real-world setting'in Belgium. Design: Retrospective, observational, multicenter cohort …

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

R Nasreddine, E Florence… - AIDS (London …, 2020 - pubmed.ncbi.nlm.nih.gov
Objective To describe the treatment outcomes of patients receiving dolutegravir (DTG) in
a'real-world setting'in Belgium. Design Retrospective, observational, multicenter cohort …

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients

R Nasreddine, E Florence, B Vandercam, M Moutschen… - AIDS, 2020 - journals.lww.com
Objective: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in a
'real-world setting'in Belgium. Design: Retrospective, observational, multicenter cohort …

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

R Nasreddine, E Florence, B Vandercam, M Moutschen… - 2020 - cabidigitallibrary.org
Objective: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in
a'real-world setting'in Belgium. Design: Retrospective, observational, multicenter cohort …

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

R Nasreddine, E Florence, B Vandercam… - AIDS (London …, 2020 - europepmc.org
Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian
cohort of 4101 HIV patients. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

[PDF][PDF] Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a belgian cohort of 4101 HIV patients

R NASREDDINE, E FLORENCE, B VANDERCAM… - lirias.kuleuven.be
Objective: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in a
'realworld setting'in Belgium. Design: Retrospective, observational, multicenter cohort …

Effectiveness of dolutegravir-based antiretroviral therapy in a real-world setting in a Belgian cohort of 4101 HIV patients.

R Nasreddine, E Florence, B Vandercam, M Moutschen… - AIDS, 2020 - dial.uclouvain.be
OBJECTIVE: To describe the treatment outcomes of patients receiving dolutegravir (DTG) in
a'real-world setting'in Belgium. DESIGN: Retrospective, observational, multicenter cohort …